SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa’s local manufacturing goals. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Biovac’s expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log...
Biovac secures major funding for African vaccine manufacturing. The expansion is supported with funds from the EIB and IFC. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
South Africa’s local drug makers are pressing the National Department of Health to change course on upcoming procurement. The issue of local pharmaceutical manufacturing is at the heart of their concerns. Pharmaceuticals Made in South Africa (Pharmisa) says domestic...
